Key Insights:
- Market Growth: Understand the significant growth trajectory of the Adult Stem Cells segment, which is expected to reach US$16 Billion by 2030 with a CAGR of 7.2%. The Other Product Types segment is also set to grow at 8.5% CAGR over the next 7 years.
- Regional Analysis: Gain insights into the U.S. market, estimated at $3.5 Billion in 2023, and China, forecasted to grow at an impressive 6.8% CAGR to reach $3.3 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Stem Cells Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Stem Cells Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Stem Cells Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as apceth Biopharma GmbH, Athersys Inc., AVIVA BioSciences Corporation, and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 233 Featured):
- apceth Biopharma GmbH
- Athersys Inc.
- AVIVA BioSciences Corporation
- BioE Inc.
- Bone Therapeutics SA
- Cesca Therapeutics Inc.
- Cryo-Cell International Inc.
- Cytori Therapeutics Inc.
- ESI BIO
- Gamida Cell Ltd.
- Holostem Terapie Avanzate
- International Stem Cell Corp.
- Kangstem Biotech. Ltd.
- Lonza Group Ltd.
- Mesoblast Ltd.
- Neuralstem Inc.
- Nuvasive Inc.
- OncoMed Pharmaceuticals Inc.
- Osiris Therapeutics Inc.
- Promethera Biosciences S.A.N.V
- Reliance Life Sciences
- ReNeuron Group Plc.
- Stemcell Technologies Inc.
- Stemedica Cell Technologies Inc.
- Stempeutics Research Pvt. Ltd.
- Takara Bio USA Inc.
- TiGenix NV
- U.S Stem Cell Inc.
- ViaCord
MarketGlass Platform
Our reports are enhanced by the MarketGlass platform, which brings together industry experts and influencers to provide high-quality, accurate insights. This unique platform allows us to gather comprehensive data and market perspectives, ensuring you receive the most reliable and detailed analysis available.Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- apceth Biopharma GmbH
- Athersys Inc.
- AVIVA BioSciences Corporation
- BioE Inc.
- Bone Therapeutics SA
- Cesca Therapeutics Inc.
- Cryo-Cell International Inc.
- Cytori Therapeutics Inc.
- ESI BIO
- Gamida Cell Ltd.
- Holostem Terapie Avanzate
- International Stem Cell Corp.
- Kangstem Biotech. Ltd.
- Lonza Group Ltd.
- Mesoblast Ltd.
- Neuralstem Inc.
- Nuvasive Inc.
- OncoMed Pharmaceuticals Inc.
- Osiris Therapeutics Inc.
- Promethera Biosciences S.A.N.V
- Reliance Life Sciences
- ReNeuron Group Plc.
- Stemcell Technologies Inc.
- Stemedica Cell Technologies Inc.
- Stempeutics Research Pvt. Ltd.
- Takara Bio USA Inc.
- TiGenix NV
- U.S Stem Cell Inc.
- ViaCord
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 369 |
Published | May 2024 |
Forecast Period | 2023 - 2030 |
Estimated Market Value ( USD | $ 11.6 Billion |
Forecasted Market Value ( USD | $ 19.1 Billion |
Compound Annual Growth Rate | 7.4% |
Regions Covered | Global |